These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22885677)
21. [A 4-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 4-week recovery test]. Oda S; Ide M; Tamura K; Nagatani M; Shindo Y; Iwakura K; Sumi N J Toxicol Sci; 1996 Jun; 21 Suppl 1():71-88. PubMed ID: 8709170 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
25. [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(4)--A perinatal and postnatal study in rats by oral administration]. Morinaga T; Fujii S; Okazaki I; Kikumori M; Nishimori T; Shindo Y; Watanabe M; Sumi N J Toxicol Sci; 1996 Jun; 21 Suppl 1():219-30. PubMed ID: 8709163 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a MEPS-UHPLC-PDA method for determination of ulifloxacin in human plasma and urine of patients with peripheral arterial disease. Ferrone V; Carlucci M; Palumbo P; Carlucci G J Pharm Biomed Anal; 2016 Sep; 128():313-321. PubMed ID: 27318081 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography. Pellegrino RM; Segoloni F; Cagini C J Pharm Biomed Anal; 2008 Jul; 47(3):567-74. PubMed ID: 18339505 [TBL] [Abstract][Full Text] [Related]
29. [A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test]. Ishibashi S; Nakazawa M; Tawaratani T; Uchimoto H; Yoshida M; Iwakura K; Sumi N; Shindo Y J Toxicol Sci; 1996 Jun; 21 Suppl 1():89-111. PubMed ID: 8709171 [TBL] [Abstract][Full Text] [Related]
30. [A photoallergenicity study of prulifloxacin (NM441) in guinea pigs]. Kamata K; Ogawa A; Inoue T; Ishihara M; Ishimura K; Sumi N; Asaoka H; Shindo Y J Toxicol Sci; 1996 Jun; 21 Suppl 1():259-65. PubMed ID: 8709166 [TBL] [Abstract][Full Text] [Related]
31. Prulifloxacin: clinical studies of a broad-spectrum quinolone agent. Giannarini G; Tascini C; Selli C Future Microbiol; 2009 Feb; 4(1):13-24. PubMed ID: 19207096 [TBL] [Abstract][Full Text] [Related]
32. [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(1)--A fertility study in rats by oral administration]. Morinaga T; Fujii S; Furukawa S; Kikumori M; Yasuhira K; Shindo Y; Watanabe M; Sumi N J Toxicol Sci; 1996 Jun; 21 Suppl 1():171-85. PubMed ID: 8709160 [TBL] [Abstract][Full Text] [Related]
33. Role of prulifloxacin in the treatment of acute rhinosinusitis. Passali D; Crisanti A; Bellussi LM Infez Med; 2015 Dec; 23(4):301-6. PubMed ID: 26700078 [TBL] [Abstract][Full Text] [Related]
34. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial. Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091 [TBL] [Abstract][Full Text] [Related]
35. Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis. Cazzola M; Salvatori E; Dionisio P; Allegra L Pulm Pharmacol Ther; 2006; 19 Suppl 1():30-7. PubMed ID: 16359895 [TBL] [Abstract][Full Text] [Related]
36. Stability study of Prulifloxacin and Ulifloxacin in human plasma by HPLC-DAD. Locatelli M; Cifelli R; Carlucci G; Romagnoli A J Enzyme Inhib Med Chem; 2016; 31(1):106-11. PubMed ID: 25683081 [TBL] [Abstract][Full Text] [Related]
37. (99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation. Shah SQ; Khan AU; Khan MR Nuklearmedizin; 2011; 50(3):134-40. PubMed ID: 21340097 [TBL] [Abstract][Full Text] [Related]
38. [A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test]. Yoshida M; Kawaminami A; Tawaratani T; Uchimoto H; Ishibashi S; Iwakura K; Sumi N; Shindo Y J Toxicol Sci; 1996 Jun; 21 Suppl 1():113-29. PubMed ID: 8709156 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys. Okuyama Y; Morino A Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548 [TBL] [Abstract][Full Text] [Related]
40. Determination of gemifloxacin in different tissues of rat after oral dosing of gemifloxacin mesylate by LC-MS/MS and its application in drug tissue distribution study. Roy B; Das A; Bhaumik U; Sarkar AK; Bose A; Mukharjee J; Chakrabarty US; Das AK; Pal TK J Pharm Biomed Anal; 2010 Jun; 52(2):216-26. PubMed ID: 20092976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]